Arcellx, Inc. , a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases.
Arcellx stock last closed at $114.77, up 0.38% from the previous day, and has increased 60.76% in one year. It has overperformed other stocks in the Biotechnology industry by 1.08 percentage points. Arcellx stock is currently +139.8% from its 52-week low of $47.86, and -0.12% from its 52-week high of $114.91.
There are currently 58.48M shares of ACLX outstanding. The market capitalization of ACLX is $6.71B. In the past 24 hours, 3.17M ACLX shares were traded.
How to Buy Arcellx Stock
Wondering how to invest in Arcellx stock? Here's how.
Choose where to buy Arcellx stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you determine where to buy Arcellx stock.
Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Fund your investment account: Pick your payment method and add your information.
Analyze Arcellx stock: The Arcellx ticker symbol is ACLX. Is Arcellx stock a good investment? Should you buy shares of ACLX? How do ACLX's underlying business fundamentals look? Do top analysts think Arcellx is a good buy? Why has ACLX's stock price moved recently? (Hint: Our stock research tools can help you decide if ACLX is a good stock to buy).
Execute your ACLX buy order: Decide if you will purchase ACLX shares at the current market price or use a limit order to buy ACLX stock at a given price.
Get key alerts regarding your ACLX investment: Create a watchlist to get the latest news on your new investment in Arcellx stock.
Step 1: Choose where to buy Arcellx stock
You need an online brokerage account in order to access the NASDAQ market and buy ACLX shares.
A brokerage account is an investment account that enables you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our experience, eToro is the best brokerage. Here's why:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to world markets: From Tech to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've chosen your brokerage, the next step is to fill out some personal info so you are able to buy ACLX today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Arcellx stock
Once you have selected the best place to buy Arcellx stock, it's very important to evaluate their stock prior to buying, so you actually understand the risk and opportunity.
Arcellx Metrics
ACLX Price
$114.77
1w %
0.33%
1y %
60.76%
5y %
N/A
P/E
-28.2x
P/B
16.68x
P/S
289.82x
PEG
N/A
Revenue
$22.29M
Earnings
-$228.93M
Fore. Rev. Growth
172.22%
Fore. Earn. Growth
N/A
Market Cap
$6.71B
Next Earnings
N/A
Next Dividend
N/A
Arcellx Due Diligence Score
WallStreetZen was created to help everyday investors perform better fundamental analysis.
Total ACLX debt is lower than 5 years ago, relative to shareholder equity.
ACLX has cash burn of 212585000. It has sufficient cash and short-term investments to cover this for at least one year.
ACLX has $450.33M in cash and short term investments. This is enough to cover its annual cash burn of $212.59M.
There are more short-term assets than short-term liabilities on the ACLX balance sheet.
There are more short-term assets than long-term liabilities on the ACLX balance sheet.
Failed Financial Due Diligence Checks:
ACLX profit margin has gone down from -99.5% to -1,027.3% in the past year.
ACLX has a relatively high debt to equity ratio of 0.5.
Is Arcellx stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 13 Equities analysts who monitor ACLX, the consensus analyst rating on ACLX is a Hold
It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.
Most Recent ACLX Analyst Forecasts
Daina Graybosch, a bottom 2% analyst from Leerink Partners downgrades ACLX to a hold rating and announces their ACLX price target of $115.00, on Feb 24, 2026.
Stephen Willey, a top 25% analyst from Stifel Nicolaus downgrades ACLX to a hold rating and lowers their ACLX price target from $127.00 to $115.00, on Feb 24, 2026.
Emily Bodnar, a bottom 3% analyst from HC Wainwright & Co. downgrades ACLX to a hold rating and maintains their ACLX price target from $115.00 to $115.00, on Feb 23, 2026.
Jack Allen, a bottom 2% analyst from Baird downgrades ACLX to a hold rating and raises their ACLX price target from $106.00 to $115.00, on Feb 23, 2026.
Yanan Zhu, a top 23% analyst from Wells Fargo downgrades ACLX to a hold rating and announces their ACLX price target of $115.00, on Feb 23, 2026.
You can dive deeper into what analysts are projecting on the Arcellx stock forecast page.
ACLX Technicals
SMA10
114.46
SMA20
114.23
SMA50
86.59
SMA100
81.38
SMA200
77.34
MACD
8.36
MACD Signal
9.77
MACD Histogram
-1.41
RSI
82.98
Stochastic %K
71.84
Stochastic %D
71.36
StochRSI %K
17.73
StochRSI %D
19.05
How are ACLX Revenues/Earnings doing?
Last year, ACLX revenue was $22.29M. Over the last two year, ACLX's revenue has increased by -55.05% per year. This was slower than the Biotechnology industry average of 29.04%.
In the past year, insiders at ACLX have sold more shares than they have bought.
Rami Elghandour, President CEO and Chairman of the Board of ACLX, was the latest ACLX insider to sell. They sold $10,243,230.72 worth of ACLX shares on Feb 27, 2026.
No, Arcellx doesn't provide an income stream by paying out dividends.
What others are saying about ACLX
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Execute your ACLX buy order
There are two primary types of orders:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are generally fine for most investors.
Limit order: A limit order allows you to buy or sell a security at a specific price (or better). If you want to be sure you're buying or selling at an exact dollar amount limit, place a limit order.
Press the Open button and eToro will execute your order.
If you want additional help with investing in stocks on eToro, click the helpful video below:
As of Mar 20, 2026, it costs $114.77 to buy one share of Arcellx stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.087 shares of ACLX.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.